Guidelines International Network | Guidelines International Network (GIN)

Pijn bij kanker. National evidence-based guideline

MeSH Terms: Cancer / Neoplasms (C04); Signs and Symptoms (C23.888); Therapeutics (E02); Pain (C23.888.646); Anesthesia and Analgesia (E03)
English Title Translation: Cancer Pain
Publication Scope: management; prevention
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch
Authors: IKNL (NL)
Publication Year: 2008

MeSH Terms: Patient Care (N02.421.585); Signs and Symptoms (C23.888); Palliative Care (N02.421.585.666); Pain (C23.888.646)
English Title Translation: Pain
Publication Scope: assessment; management; prevention
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch
Authors: IKNL (NL)
Publication Year: 2010

MeSH Terms: Central Nervous System Diseases (C10.228); Epilepsy (C10.228.140.490)
Guideline Contact: Raija Sipilä ([email protected])
English Title Translation: Prolonged epileptic seizure and status epilepticus
Publication Date: 6.2.2026
Publication Scope: assessment; management
Countries of Application: Finland
Guideline Publication Status: Published
Languages: Finnish
Authors: CC (FI)
Publication Year: 2026

MeSH Terms: Neonatal Screening (E01.370.225.910); Neonatal Screening (E01.370.500.580); Neonatal Screening (E05.318.308.250.580.580); Neonatal Screening (E05.200.910); Neonatal Screening (N02.421.143.827.233.443.816); Neonatal Screening (N05.715.360.300.375.500.575); Neonatal Screening (N06.850.780.500.580); Neonatal Screening (N06.850.520.308.250.580.580); France (Z01.542.286); Cystic Fibrosis (C06.689.202); Cystic Fibrosis (C08.381.187); Cystic Fibrosis (C16.320.190); Cystic Fibrosis (C16.614.213); Biological Markers (D23.101)
Publication Scope: assessment; counselling; implementation; management; patient_education; prevention; prognosis; rehabilitation; screening; treatment
Countries of Application: France
Guideline Publication Status: Published
Languages: French
Authors: HAS (FR)
Publication Year: 2015

MeSH Terms: Mass Screening (N02.421.143.827.233.443); Mass Screening (N02.421.726.233.443); Mass Screening (N05.715.360.300.375.500); Mass Screening (N06.850.520.308.250.580); Mass Screening (N06.850.780.500); Hepatitis B (C02.256.430.400); Hepatitis B (C02.440.435); Hepatitis B (C06.552.380.705.437); Hepatitis B virus (B04.280.375.650.425); Hepatitis B virus (B04.450.390.650.425); Hepatitis B virus (B04.909.204.340.650.425); Mass Screening (E01.370.500); Mass Screening (E05.318.308.250.580)
Publication Scope: screening
Countries of Application: France
Guideline Publication Status: Published
Languages: French
Authors: HAS (FR)
Publication Year: 2016

MeSH Terms: Health Services (N02.421); Genetic Markers (D23.101.387); Genetic Counseling (N02.421.308.400); Genetic Testing (N02.421.308.430); Health Resources (N03.349.340)
Guideline Contact: Iñaki Gutierrez-Ibarluzea ([email protected])
English Title Translation: Plan for the development of genetics in the Basque Country
Publication Scope: management
Countries of Application: Spain
Guideline Publication Status: Published
Languages: Spanish
Authors: OSTEBA (ES)
Publication Year: 2011

MeSH Terms: Aged (M01.060.116.100); Patient-Centered Care (N04.590.233.675); Patient-Centered Care (N04.590.233.727.407); Patient-Centered Care (N04.590.720); Patient Care Team (N04.590.715); Disease Management (N04.590.607)
Publication Scope: assessment; counselling; implementation; management; patient_education; prevention
Countries of Application: France
Guideline Publication Status: Published
Languages: French
Authors: HAS (FR)
Publication Year: 2015